Semaglutide treatment in a regular clinical setting was associated with weight loss
Researchers at Mayo Clinic in a study published in the JAMA journal found that semaglutide treatment in a regular clinical setting was associated with weight loss. Obesity is a chronic, multifactorial, and relapsing disease with an increasing prevalence estimated to reach 49% by 2030. Its medical burden includes multiple comorbidities, such as type 2 diabetes, […]
